IM Cannabis Corp. (IMCC) Stock Analysis & Investment Frameworks
IM Cannabis Corp. (IMCC) stock analysis on Invetso. Review IM Cannabis Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
IM Cannabis Corp. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: CA
IM Cannabis Corp. Key Financial Metrics
- Market Cap: $1.06M
- Revenue: $39.48M
- ROE: -3.03%
- ROIC: -0.91%
- Dividend Yield: N/A
About IM Cannabis Corp.
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
IM Cannabis Corp. Investment Frameworks
Invetso analyzes IM Cannabis Corp. (IMCC) across the following frameworks:
- IM Cannabis Corp. 10Y Growth Potential
- IM Cannabis Corp. Scenario Analysis
- IM Cannabis Corp. Risks & Opportunities
- IM Cannabis Corp. Economic Moat
- IM Cannabis Corp. Business Model
- IM Cannabis Corp. Management
- IM Cannabis Corp. SWOT Analysis
- IM Cannabis Corp. Porter's 5 Forces
- IM Cannabis Corp. PESTLE Analysis
- IM Cannabis Corp. ESG Analysis
